Warning: fopen(/home/virtual/epih/journal/upload/ip_log/ip_log_2023-06.txt): failed to open stream: Permission denied in /home/virtual/lib/view_data.php on line 83 Warning: fwrite() expects parameter 1 to be resource, boolean given in /home/virtual/lib/view_data.php on line 84 Disease burden of prostate cancer from 2014 to 2019: estimation from the Global Burden of Disease Study 2019 and Medical Expenditure Panel Survey
Skip Navigation
Skip to contents

Epidemiol Health : Epidemiology and Health

OPEN ACCESS
SEARCH
Search
Advanced Search
mobile menu button

Articles

Page Path
HOME > Epidemiol Health > Accepted Articles > Article
Original article Disease burden of prostate cancer from 2014 to 2019: estimation from the Global Burden of Disease Study 2019 and Medical Expenditure Panel Survey
Shen Lin1,2orcid , Dong Lin1,2orcid , Yiyuan Li3orcid , Lixian Zhong4orcid , Wei Zhou5orcid , Yajing Wu1,2orcid , Chen Xie1,2orcid , Shaohong Luo1,2orcid , Xiaoting Huang1,2orcid , Xiongwei Xu1,2orcid , Xiuhua Weng1,2orcid
Epidemiol Health 2023;e2023038
DOI: https://doi.org/10.4178/epih.e2023038 [Accepted]
Published online: March 21, 2023
  • 590 Views
  • 30 Download
  • 0 Crossref
  • 0 Scopus
1First Affiliated Hospital of Fujian Medical University, Fuzhou, China
2National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, China
3Shishi General Hospital, Quanzhou, China
4Texas A&M University，College Station, TX, United States
5Journal Center of The First Affiliated Hospital of Fujian Medical University, Fuzhou, China
Corresponding author:  Xiongwei Xu,
Email: wxh001@fjmu.edu.cn
Xiuhua Weng,
Email: wxh001@fjmu.edu.cn
Received: 20 December 2022   • Revised: 21 February 2023   • Accepted: 27 February 2023
Full Article

Download PDF Download PDF

Abstract

Objectives
The aim of this study was to evaluate the disease burden of prostate cancer (PC) and assess key influencing factors associated with the disease expenditures of PC in the United States (US).
Methods
The total deaths, incidence, prevalence, and disability-adjusted life-years of PC were obtained from the Global Burden of Disease Study 2019. The Medical Expenditure Panel Survey was used to estimate healthcare expenditures and productivity loss and to investigate patterns of payment and use of healthcare resources in the US. A multivariable logistic regression model was conducted to identify key factors influencing expenditures.
Results
For patients aged 50 and older, the burden for all age groups showed a modest increase over the 6-year period. Annual medical expenditures were estimated to range from $24.8 to $39.2 billion from 2014 to 2019. The annual loss in productivity for patients was approximately $1,200. The top 3 major components of medical costs were hospital inpatient stays, prescription medicines, and office-based visits. Medicare was the largest source of payments for survivors. In terms of drug consumption, genitourinary tract agents (57.0%) and antineoplastics (18.6%) were the main therapeutic drugs. High medical expenditures were positively associated with age (P=0.005), having private health insurance (P=0.016), more comorbidities, not currently smoking (P=0.001), and patient self-perception of fair/poor health status (P<0.001).
Conclusions
From 2014 to 2019, the national real-world data of PC revealed that the disease burden in the US continued to increase, which was partly related to patient characteristics

Epidemiol Health : Epidemiology and Health
© Korean Society of Epidemiology.